Atlas Trials

Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies

Clinical trial NCT06135584 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06135584
Sponsor
The Affiliated Hospital of Hangzhou Normal University
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Metabolic Dysfunction-associated Fatty Liver DiseaseCirrhosis
Start date
2023-11-18
Primary completion
2026-12-31
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.